Citation Impact
Citing Papers
Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes
2018 StandoutScienceNobel
On the relationship between folding and chemical landscapes in enzyme catalysis
2008 StandoutNobel
Functional Extinction of Birds Drives Rapid Evolutionary Changes in Seed Size
2013 StandoutScience
Globo-H Ceramide Shed from Cancer Cells Triggers Translin-Associated Factor X-Dependent Angiogenesis
2014
Dendritic Cells Express Multiple Chemokine Receptors Used as Coreceptors for HIV Entry
1998 StandoutNobel
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy
2022 StandoutNobel
Discovery and optimization of nonpeptide HIV-1 protease inhibitors
1996
Retinoic acid receptors: From molecular mechanisms to cancer therapy
2014
Crystal Structures of the Bacillus stearothermophilus CCA-Adding Enzyme and Its Complexes with ATP or CTP
2002 StandoutNobel
Agricultural sustainability and intensive production practices
2002 StandoutNature
mRNA-based therapeutics — developing a new class of drugs
2014 StandoutNobel
Structural and biochemical studies of retroviral proteases
2000
Structure of the Replicating Complex of a Pol α Family DNA Polymerase
2001 StandoutNobel
Ordered accumulation of mutations in HIV protease confers resistance to ritonavir
1996
The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994
1999 Standout
Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M+ diffuse midline gliomas
2018
Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy
1997 Standout
Tuberculosis in Patients with Human Immunodeficiency Virus Infection
1999 Standout
Killing HIV-infected cells by transduction with an HIV protease-activated caspase-3 protein
1999
Cyclopropane-Derived Peptidomimetics. Design, Synthesis, Evaluation, and Structure of Novel HIV-1 Protease Inhibitors
1998
Engineered T cells: the promise and challenges of cancer immunotherapy
2016
Natural Killer Cell Mediated Antibody-Dependent Cellular Cytotoxicity in Tumor Immunotherapy with Therapeutic Antibodies
2013
Structures of phi29 DNA polymerase complexed with substrate: the mechanism of translocation in B‐family polymerases
2007 StandoutNobel
Predicting Drug‐Resistant Mutations of HIV Protease
2007 StandoutNobel
Engineering CAR-T cells: Design concepts
2015
Insights into Strand Displacement and Processivity from the Crystal Structure of the Protein-Primed DNA Polymerase of Bacteriophage φ29
2004 StandoutNobel
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
Escape mutants of HIV-1 proteinase: enzymic efficiency and susceptibility to inhibition
1997
Tumour-associated macrophages and cancer
2013
Synergistic Innate and Adaptive Immune Response to Combination Immunotherapy with Anti-Tumor Antigen Antibodies and Extended Serum Half-Life IL-2
2015
Unmet information and support needs in newly diagnosed thyroid cancer: comparison of adolescents/young adults (AYA) and older patients
2014
Kinetic Characterization of Human Immunodeficiency Virus Type-1 Protease-resistant Variants
1996
Enhancing Cancer Immunotherapy Via Activation of Innate Immunity
2015
Hepatitis C, Hepatitis B, and Human Immunodeficiency Virus Infections among Non-Intravenous Drug-Using Patients Attending Clinics for Sexually Transmitted Diseases
1994
Defining the Anthropocene
2015 StandoutNature
The Structural Mechanism of Translocation and Helicase Activity in T7 RNA Polymerase
2004 StandoutNobel
Inhibitors of HIV‐1 Protease by Using In Situ Click Chemistry
2006 StandoutNobel
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
2014 Standout
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
DNA Polymerases: Structural Diversity and Common Mechanisms
1999 StandoutNobel
Insights into the Replisome from the Structure of a Ternary Complex of the DNA Polymerase III α-Subunit
2008 StandoutNobel
Protein Sequence Editing of SKN-1A/Nrf1 by Peptide:N-Glycanase Controls Proteasome Gene Expression
2019 StandoutNobel
Validating the vitality strategy for fighting drug resistance
2011 StandoutNobel
Regimen-Specific Effects of RNA-Modified Chimeric Antigen Receptor T Cells in Mice with Advanced Leukemia
2013
Inhibitors of HIV Nucleocapsid Protein Zinc Fingers as Candidates for the Treatment of AIDS
1995 Science
Molecular Recognition of Protein−Ligand Complexes: Applications to Drug Design
1997 Standout
HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time
1996 StandoutScience
Human immunodeficiency virus type 1 proteinase resistance to symmetric cyclic urea inhibitor analogs
1997
Converting structural information into an allosteric-energy-based picture for elongation factor Tu activation by the ribosome
2011 StandoutNobel
Antitumor activity and long-term fate of chimeric antigen receptor–positive T cells in patients with neuroblastoma
2011
Engineering a Single-Agent Cytokine/Antibody Fusion That Selectively Expands Regulatory T Cells for Autoimmune Disease Therapy
2018
Structure of the STRA6 receptor for retinol uptake
2016 StandoutScienceNobel
Adoptive cell transfer as personalized immunotherapy for human cancer
2015 StandoutScience
Biodiversity Conservation and the Eradication of Poverty
2004 StandoutScience
The Galvanization of Biology: A Growing Appreciation for the Roles of Zinc
1996 StandoutScience
Implicit Solvation Models: Equilibria, Structure, Spectra, and Dynamics
1999 Standout
Bacterial Resistance to β-Lactam Antibiotics: Compelling Opportunism, Compelling Opportunity
2005 Standout
Structure of a Covalently Trapped Catalytic Complex of HIV-1 Reverse Transcriptase: Implications for Drug Resistance
1998 StandoutScience
Phase I Trial of a Bivalent Gangliosides Vaccine in Combination with β-Glucan for High-Risk Neuroblastoma in Second or Later Remission
2014
Stereoselective Cyclopropanation Reactions
2003 Standout
Analysis of the S3 and S3′ subsite specificities of feline immunodeficiency virus (FIV) protease: Development of a broad-based protease inhibitor efficacious against FIV, SIV, and HIV in vitro and ex vivo
1998
Polyoxometalates in Medicine
1998 Standout
Computational study of protein specificity: The molecular basis of HIV-1 protease drug resistance
2001
The Combinatorial Synthesis of Bicyclic Privileged Structures or Privileged Substructures
2003 Standout
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
Climate Warming and Disease Risks for Terrestrial and Marine Biota
2002 StandoutScience
Antiretroviral effect of zidovudine–didanosine combination on blood and lymph nodes
1997
Dinutuximab
2016
Structure of HIV-1 reverse transcriptase bound to an inhibitor active against mutant reverse transcriptases resistant to other nonnucleoside inhibitors
2004 StandoutNobel
Defaunation in the Anthropocene
2014 StandoutScience
Human serum alpha 1 acid glycoprotein reduces uptake, intracellular concentration, and antiviral activity of A-80987, an inhibitor of the human immunodeficiency virus type 1 protease
1996
The Future Is Now: Chimeric Antigen Receptors as New Targeted Therapies for Childhood Cancer
2012
Calculation of Relative Binding Free Energies of Peptidic Inhibitors to HIV-1 Protease and Its I84V Mutant
1998
Antigen specificity can be irrelevant to immunocytokine efficacy and biodistribution
2015
Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy
1997 StandoutScience
ABT-538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability in humans.
1995
CAR T cell immunotherapy for human cancer
2018 StandoutScience
A Phase I Study of the Anti-Idiotype Vaccine Racotumomab in Neuroblastoma and Other Pediatric Refractory Malignancies
2015
N‐Carboxyanhydride Polymerization of Glycopolypeptides That Activate Antigen‐Presenting Cells through Dectin‐1 and Dectin‐2
2018 StandoutNobel
Humans as the World's Greatest Evolutionary Force
2001 Science
In Vivo Protein Transduction: Delivery of a Biologically Active Protein into the Mouse
1999 StandoutScience
Structure of the catalytic domain of the hepatitis C virus NS2-3 protease
2006 StandoutNatureNobel
Comparative Studies on Retroviral Proteases: Substrate Specificity
2010
Works of Barry Anderson being referenced
Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma
2010
Kinetic Characterization and Cross-Resistance Patterns Of HIV-1 Protease Mutants Selected under Drug Pressure
1995
The distinctive biology of cancer in adolescents and young adults
2008
Human Immunodeficiency Virus Type 1 (HIV-l) Viremia Changes and Development of Drug-Related Mutations in Patients with Symptomatic HIV-l Infection Receiving Alternating or Simultaneous Zidovudine and Didanosine Therapy
1995
Protein binding of human immunodeficiency virus protease inhibitor KNI-272 and alteration of its in vitro antiretroviral activity in the presence of high concentrations of proteins
1994
Changes in drug sensitivity of human immunodeficiency virus type 1 during therapy with azidothymidine, dideoxycytidine, and dideoxyinosine: an in vitro comparative study.
1993